-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

722.O2.6 722. Clinical Allogeneic Transplantation: Acute and Chronic GvHD, Immune Reconstitution: Pathobiology and Predictive Biomarkers

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, Biological, HSCs, antibodies, viral, bioengineering, Diseases, Therapies, GVHD, cell regulation, Pediatric, Biological Processes, white blood cells, Technology and Procedures, cell expansion, Immune Disorders, immune cells, epigenetics, Cell Lineage, Infectious Diseases, Lymphoid Malignancies, Study Population, gene editing, Clinically relevant, genetic profiling, genomics, Myeloid Malignancies, transplantation, immune mechanism, flow cytometry, molecular testing, serologic tests, pathogenesis
Sunday, December 6, 2020: 12:00 PM-1:30 PM
Moderators:
Brian G. Engelhardt, MD, Vanderbilt University Medical Center and Joseph Pidala, MD, H. Lee Moffitt Cancer Center and Research Institute
Disclosures:
Pidala: Syndax: Consultancy, Membership on an entity's Board of Directors or advisory committees; CTI Biopharma: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Amgen: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Novartis: Research Funding; Takeda: Research Funding; Janssen: Research Funding; Johnson and Johnson: Research Funding; Pharmacyclics: Research Funding; Abbvie: Research Funding; BMS: Research Funding.
12:00 PM

Benedetta Rambaldi, MD1,2, Haesook T. Kim, PhD3, Carol Reynolds, PhD1*, Sharmila Chamling Rai, BSc1*, Takeru Asano, MD, PhD1*, Yohei Arihara, MD, PhD1*, Mahasweta Gooptu, MD1, John Koreth, MBBS, DPhil1, Corey Cutler, MD, MPH, FRCPC 1, Sarah Nikiforow, MD, PhD1, Vincent T. Ho, MD4*, Joseph H. Antin, MD1, Rizwan Romee, MD1, Robert J. Soiffer, MD1, Jeanette Ampudia5*, Cherie Tracy Ng, PhD, MPH5*, Stephen Connelly, PhD, MBA5* and Jerome Ritz, MD1

1Dana-Farber Cancer Institute, Department of Hematologic Malignancies and Harvard Medical School, Boston, MA
2DIMET, University of Milano-Bicocca, Monza, Italy
3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
5Equillium, Inc, La Jolla, CA

12:15 PM

Geoff D.E. Cuvelier, MD1, Amina Kariminia, PhD2*, Eneida R. Nemecek, MD, MBA, MSc3, Carrie Kitko, MD4, Justin T. Wahlstrom, MD5, Andrew C Harris, MD6*, Henrique Bittencourt, MD, PhD7, Victor A. Lewis, MD8, Michael A Pulsipher, MD9, Tal Schechter-Finkelstein, MD10, Sung W. Choi, MD11, Emi Caywood, MD12, Monica Bhatia, MD13*, Kimberly A. Kasow, DO14*, David Jacobsohn, MD15, Benjamin Oshrine, MD16*, Sonali Chaudhury, MD17*, Joseph H. Chewning, MD18*, Flower Allyson, MD19*, Don W. Coulter, MD20, Michael J. Joyce, MD21*, Sureyya Savasan, MD22, Anna Pawlowska, MD23*, Gail Megason, MD24*, David Mitchell, MD25*, Alexandra Cheerva, MD26*, Anita Lawitschka, MD27*, Bernard Ng, PhD28* and Kirk R. Schultz, MD29

1Pediatric Blood and Marrow Transplant, Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada
2British Columbia Children's Hospital, B.C. Children's Hospital Research Institute, University of British Columbia, Vancouver, Bc, CAN
3Pediatric Hematology/Oncology & Bone Marrow Transplantation, Oregon Health & Science University, Knight Cancer Institute Doernbecher Children's Hospital, Portland, OR
4Pediatric Blood and Marrow Transplantation Program, Vanderbilt University Medical Center, Nashville, TN
5UCSF Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA
6Primary Children's Hospital, University of Utah, Salt Lake City, UT
7Hematology-Oncology Division, Charles Bruneau Cancer Center, CHU Sainte-Justine, University de Montreal, Montreal, QC, Canada
8Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada
9Children's Hospital of Los Angeles, Los Angeles, CA
10The Hospital for Sick Children, Toronto, Canada
11Blood and Marrow Transplant Program, C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, MI
12Nemours Alfred I. Dupont Hospital For Children, Wilmington, DE
13Division of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Columbia University Medical Center, New York, NY
14University of North Carolina At Chapel Hill, Chapel Hill, NC
15Children’S National Med. Ctr., Ctr. For Cancer & Blood Disorders, Washington, DC
16John Hopkins All Children's Hospital, St. Petersburg, FL
17Lurie Children's Hospital of Chicago, Chicago, IL
18University of Alabama at Birmingham, Birmingham, AL
19New York Medical College, Valhalla, NY
20University of Nebraska Medical Center, Omaha, NE
21Nemours Children's Hospital, Jacksonville, FL
22Children's Hospital of Michigan, Division of Hematology/Oncology, BMT Program, Karmanos Cancer Center, Wayne State University, Detroit, MI
23CIty of Hope, Duarte, CA
24Department of Pediatrics Hematology/Oncology, University of Mississippi Medical Center, Jackson, MS
25Montreal Children's Hospital, McGill University Health Center, Montreal, QC, Canada
26Norton Children's Hospital, University of Louisville, Louisville, KY
27St Anna Children's Hospital, Medical University Vienna, Vienna, Austria
28Department of Statistics, University of British Columbia, Vancouver, BC, Canada
29British Columbia Children's Hospital, BC Children's Hospital Research Institiute, University of British Columbia, Vancouver, BC, Canada

12:30 PM

Merav Bar1, Darawan Rinchai2*, Mohammed Toufiq2*, Mohammed Elanbari2*, Dhanya Kizhakayil2*, Harshitha Shobha Manjunath2*, Rebecca Mathew3*, Irene M Cavattoni4*, Sabine Forer5*, Clarisa Brown6*, Nancy Miles7*, Sara Tomei3*, Chiara Cugno, MD2, Damien Chaussabel8* and Sara Deola, MD, PhD2

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Research, Sidra Medicine, Doha, Qatar
3Sidra Medicine, Doha, Qatar
4Hematology and BMT Unit, General Hospital of Bolzano, Bolzano, Italy
5General Hospital of Bolzano, Bolzano, Italy
6Fred Hutchinsons Research Cancer Center, Seattle, WA
7University of Washington, Seattle, WA
8Research, Sidra Medicine, Doha, WA, Qatar

12:45 PM

Parth Gandhi1*, Isha Gandhi1*, Andrea Hoeschen2*, Wes Mosher1*, Margaret L. MacMillan, MD3, Armin Rashidi, MD, PhD4, Najla H El Jurdi, MD5, Alexander Khoruts, MD6*, Daniel J. Weisdorf, MD7, Bruce R. Blazar, MD8, Qing Cao, MS1*, Brian C. Betts, MD5, Angela Panoskaltsis-Mortari, PhD9, Chi Chen1* and Shernan G Holtan, MD5

1University of Minnesota, Minneapolis, MN
2Clinical Trials Office, University of Minnesota, Minneapolis, MN
3Division of Pediatric Blood and Marrow Transplantation, University Of Minnesota, Minneapolis, MN
4Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Edina, MN
5Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
6Department of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN
7Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
8Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
9Pediatric Blood and Marrow Transplant (BMT) Center, University of Minnesota, Minneapolis, MN

1:00 PM

Florent Malard, MD, PhD1*, Michael Loschi, MD, PhD2*, Faezeh Legrand, MD3*, Raynier Devillier4*, Sarah Guenounou, MD5*, Cecile Borel, MD5*, Deborah Desmier, MD6*, Jérôme Cornillon, MD7*, Amandine Le Bourgeois, MD8*, Jean-Baptiste Mear, MD9*, Delphine Martineau, MD10*, Hélène Labussière, MD11*, Marie-Anne Couturier, MD12*, Claude-Eric Bulabois, MD13*, Emilie Plantamura, PhD, PharmD14* and Mohamad Mohty, MD, PhD15

1Service d'Hématologie Clinique et de Thérapie Cellulaire, Hopital Saint Antoine, Paris, France
2Hematology Department, Cote D'Azur University, CHU of Nice, Nice, France
3Hematology department, Institut Paoli Calmettes, Marseille, France
4Institut Paoli Calmettes, Marseille, France
5Institut Universitaire du Cancer de Toulouse Oncopole, Hematology Department, Toulouse, France
6CHU de Poitiers, Service d'Hématologie et de thérapie cellulaire, Poitiers, France
7Hematology department, Lucien Neuwirth Cancer Institute, Saint-Priest-en-Jarez, France
8Clinical Hematology, Nantes University Hospital, Nantes, France
9Clinical hematology, University Hospital of Rennes, Rennes, France
10CHU de Bordeaux, Hematology Department, Bordeaux, France
11Hematology department 1 G, Centre Hospitalier Lyon Sud, Pierre Benite, France
12Clinical Hematology, Brest University Hospital, Brest, France
13Hematology, CHU Grenoble Alpes - Université Grenoble Alpes, La Tronche, France
14MaaT Pharma, Lyon, France
15Hematology Department, Hôpital Saint Antoine, Service d'Hématologie et Thérapie Cellulaire, Paris, France

1:15 PM

Albert Yeh, MD1, Madan Jagasia, MBBS, MS, MMHC2, Kimberly Dahlman, PhD3*, Jonathan Michael Irish, PhD3*, Anupama Reddy, PhD4*, Sierra Barone, BS3*, Kate Chilson, MA1*, Lynn E. Onstad, ScM5*, Ping Zhang, MD, PhD1*, Tae Kon Kim, MD, PhD2, Stephanie J. Lee, MD, MPH6 and Geoff R Hill, MD1

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Vanderbilt University Medical Center, Nashville, TN
3Vanderbilt University, Nashville, TN
4Prism Bioanalytics, Morrisville, NC
5Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
6Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

*signifies non-member of ASH